Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors
- PMID: 26164590
- DOI: 10.1007/s11030-015-9614-2
Large-scale structure-activity relationship study of hepatitis C virus NS5B polymerase inhibition using SMILES-based descriptors
Abstract
Hepatitis C virus (HCV) is composed of structural and non-structural proteins involved in viral transcription and propagation. In particular, NS5B is an RNA-dependent RNA polymerase for viral transcription and genome replication and is a target for designing anti-viral agents. In this study, classification and quantitative structure-activity relationship (QSAR) models of HCV NS5B inhibitors were constructed using the Correlation and Logic software. Molecular descriptors for a set of 970 HCV NS5B inhibitors were encoded using the simplified molecular input line entry system notation, and predictive models were built via the Monte Carlo method. The QSAR models provided acceptable correlation coefficients of [Formula: see text] and [Formula: see text] in the ranges of 0.6038-0.7344 and 0.6171-0.7294, respectively, while the classification models displayed sensitivity, specificity, and accuracy in ranges of 88.24-98.84, 83.87-93.94, and 86.50-94.41 %, respectively. Furthermore, molecular fragments as substructures involved in increased and decreased inhibitory activities were explored. The results provide information on QSAR and classification models for high-throughput screening and mechanistic insights into the inhibitory activity of HCV NS5B polymerase.
Keywords: Data mining; HCV NS5B polymerase inhibitors; Hepatitis C virus; Monte Carlo method; Structure-activity relationship.
Similar articles
-
Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.J Chem Inf Model. 2014 Feb 24;54(2):539-52. doi: 10.1021/ci400644r. Epub 2014 Feb 5. J Chem Inf Model. 2014. PMID: 24460140
-
Novel Guanosine Derivatives as Anti-HCV NS5b Polymerase: A QSAR and Molecular Docking Study.Med Chem. 2019;15(2):130-137. doi: 10.2174/1573406414666181015152511. Med Chem. 2019. PMID: 30324891
-
Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.Mol Divers. 2015 Aug;19(3):529-39. doi: 10.1007/s11030-015-9591-5. Epub 2015 Apr 11. Mol Divers. 2015. PMID: 25862642
-
Recent advances on the synthesis of hepatitis C virus NS5B RNA-dependent RNA-polymerase inhibitors.Eur J Med Chem. 2015 Sep 18;102:188-214. doi: 10.1016/j.ejmech.2015.07.046. Epub 2015 Jul 31. Eur J Med Chem. 2015. PMID: 26276434 Review.
-
Recent advances in discovery and development of promising therapeutics against hepatitis C virus NS5B RNA-dependent RNA polymerase.Mini Rev Med Chem. 2005 Dec;5(12):1103-12. doi: 10.2174/138955705774933310. Mini Rev Med Chem. 2005. PMID: 16375756 Review.
Cited by
-
Mpropred: A machine learning (ML) driven Web-App for bioactivity prediction of SARS-CoV-2 main protease (Mpro) antagonists.PLoS One. 2023 Jun 23;18(6):e0287179. doi: 10.1371/journal.pone.0287179. eCollection 2023. PLoS One. 2023. PMID: 37352252 Free PMC article.
-
ML enhanced bioactivity prediction for angiotensin II receptor: A potential anti-hypertensive drug target.Sci Rep. 2025 Jul 14;15(1):25367. doi: 10.1038/s41598-025-08653-4. Sci Rep. 2025. PMID: 40659675 Free PMC article.
-
StackHCV: a web-based integrative machine-learning framework for large-scale identification of hepatitis C virus NS5B inhibitors.J Comput Aided Mol Des. 2021 Oct;35(10):1037-1053. doi: 10.1007/s10822-021-00418-1. Epub 2021 Oct 8. J Comput Aided Mol Des. 2021. PMID: 34622387
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources